Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation

Sanshuai Chang; Jianzeng Dong; Changsheng Ma; Xin Du; Jiahui Wu; Ribo Tang; Shijun Xia; Xueyuan Guo; Ronghui Yu; Deyong Long; Rong Bai; Nian Liu; Caihua Sang; Chenxi Jiang; Xiaohui Liu; Jianhong Pan; Professor Gregory Lip

doi:10.1161/strokeaha.116.012988

Related publications

Article2019

The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study

Wangyang Yang, Xin Du, Chao Jiang, Liu He, Ameenathul M. Fawzy, Lu Wang, Chang Liu, Shijun Xia, Sanshuai Chang, Xueyuan Guo, Songnan Li, Ribo Tang, Nian Liu, Rong Bai, Caihua Sang, Chenxi Jiang, Ronghui Yu, Deyong Long, Jianzeng Dong, Professor Gregory Lip, Changsheng Ma

Article2019

Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry

Ying Wang, Changsheng Ma, Xin Du, Liu He, Jie Li, Guohong Wang, Dan Wen, Jianzeng Dong, Jianhong Pan, Professor Gregory Lip

Article2016

Rationale and design of the Chinese Atrial Fibrillation Registry Study

Xin Du, Changsheng Ma, Jiahui Wu, Songnan Li, Man Ning, Ribo Tang, Xueyuan Guo, Deyong Long, Ronghui Yu, Caihua Sang, Chenxi Jiang, Ting Zhang, Jianhong Pan, Xiaohui Liu, Jianzeng Dong, Professor Gregory Lip

Article2018

Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China‐AF Study

Di Lan, Chao Jiang, Xin Du, Liu He, Xueyuan Guo, Song Zuo, Shijun Xia, Sanshuai Chang, Songnan Wen, Jiahui Wu, Yanfei Ruan, Deyong Long, Ribo Tang, Ronghui Yu, Caihua Sang, Rong Bai, Nian Liu, Chenxi Jiang, Songnan Li, Jianzeng Dong, Professor Gregory Lip, Aihua Chen, Changsheng Ma

Article2019

Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation

Mathieu Kernéis, Megan K. Yee, Roxana Mehran, Tarek Nafee, Christoph Bode, Jonathan L. Halperin, Eric D. Peterson, Freek W.A. Verheugt, Peter Wildgoose, Martin van Eickels, Professor Gregory Lip, Marc Cohen, Keith A.A. Fox, C. Michael Gibson

Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation

Abstract

Discussion(0)

Related publications

The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study

Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry

Rationale and design of the Chinese Atrial Fibrillation Registry Study

Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China‐AF Study

Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation